The vaccines developed by Pfizer and German partner BioNTech and Moderna using mRNA technology may offer protection against the coronavirus-borne illness COVID-19 for years, according to a new study published Monday.
The vaccines developed by Pfizer and German partner BioNTech and Moderna using mRNA technology may offer protection against the coronavirus-borne illness COVID-19 for years, according to a new study published Monday.